Abstract
The Cannabis plant and its products consist of an enormous variety of chemicals. Some of the 483 compounds identified are unique to Cannabis, for example, the more than 60 cannabinoids, whereas the terpenes, with about 140 members forming the most abundant class, are widespread in the plant kingdom. The term “cannabinoids” [note: “ ” represents a group of C21 terpenophenolic compounds found until now uniquely in Cannabis sativa L. (1). As a consequence of the development of synthetic cannabinoids (e.g., nabilone [2], HU-211 [dexanabinol; ref. (3), or ajulemic acid [CT-3; ref. 4]) and the discovery of the chemically different endogenous cannabinoid receptor ligands (“endocannabinoids,” e.g., anandamide, 2-arachidonoylglycerol) (5,6), the term ’“phytocannabinoids’” was proposed for these particular Cannabis constituents (7).
Keywords
- High Pressure Liquid Chromatography
- Cannabis Sativa
- Cannabis Plant
- Cannabis Product
- Cannabis Resin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Preview
Unable to display preview. Download preview PDF.
References
Mechoulam, R. and Gaoni, Y. (1967) Recent advances in the chemistry of hashish. Fortschr. Chem. Org. Naturst. 25, 175–213.
Ward, A. and Holmes, B. (1985) Nabilone. A preliminary review of its pharmacological properties and therapeutic use. Drugs 30, 127–144.
Mechoulam, R., Lander, N., Breuer, A., and Zahalka, J. (1990) Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative. Tetrahedron Asymmetry 1, 315–318.
Burstein, S. H., Audette, C. A., Breuer, A., et al. (1992) Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities. J. Med. Chem. 35, 3135–3141.
Di Marzo, V. and Fontana, A. (1995) Anandamide, an endogenous cannabinomimetic eicosanoid:’ killing two birds with one stone’. Prostaglandins Leukot. Essent. Fatty Acids 53, 1–11.
Devane, W. A., Hanus, L., Breuer, A., et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946–1949.
Pate, D. (1999) Anandamide structure-activity relationships and mechanisms of action on intraocular pressure in the normotensive rabbit model, PhD thesis, University of Kuopio, Kuopio, Finland.
Turner, C. E., Elsohly, M. A., and Boeren, E. G. (1980) Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J. Nat. Prod. 43, 169–234.
Ross, S. A. and ElSohly, M. A. (1995) Constituents of Cannabis sativa L. XXVIII-A review of the natural constituents: 1980-1994. Zagazig J. Pharm. Sci. 4, 1–10.
ElSohly, M. (2002) Chemical constituents of Cannabis, in Cannabis and cannabinoids— Pharmacology, Toxicology and Therapeutic Potential (Grotenhermen, F. and Russo, E., eds.), Haworth Press, New York, pp. 27–36.
Gaoni, Y. and Mechoulam, R. (1964) The structure and synthesis of cannabigerol, a new hashish constituent, in Proc. Chem. Soc., London, p. 82.
Shoyama, Y., Yagi, M., Nishioka, I., and Yamauchi, T. (1975) Biosynthesis of cannab-inoid acids. Phytochemistry 14, 2189–2192.
Adams, R., Hunt, M., and Clark, J. (1940) Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. I. J. Am. Chem. Soc. 62, 196–199.
Mechoulam, R. and Shvo, Y. (1963) Hashish—I. The structure of cannabidiol. Tetrahedron 19, 2073–2078.
Wollner, H., Matchett, J., Levine, J., and Loewe, S. (1942) Isolation of a physiologically active tetrahydrocannabinol from Cannabis sativa resin. J. Am. Chem. Soc. 64, 26–29.
Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646–1647.
Wood, T., Spivey, W., and Easterfield, T. (1896) XL. Charas. The resin of Indian hemp. J. Chem. Soc. 69, 539.
Adams, R., Baker, B., and Wearn, R. (1940) Structure of cannabinol III. Synthesis of cannabinol, 1-hydroxy-3-n-amyl-6,6,9-trimethyl-6-dibenzopyran. J. Am. Chem. Soc. 62, 2204–2207.
ElSohly, M., Ross, S., Mehmedic, Z., Arafat, R., Yi, B., and Banahan, B.F., 3rd (2000) Potency trends of delta-9-THC and other cannabinoids in confiscated marijuana from 1980-1997. J. Forens. Sci. 45, 24–30.
Brenneisen, R. (1986) The cannabinoid content in Cannabis products confiscated in Switzerland. Arch. Kriminol. 177, 95–104.
Brenneisen, R. and Meyer, P. Swiss Cannabis Profiling Project, University of Bern and Swiss Federal Office of Public Health (unpublished data).
Miller Coyle, H., Palmbach, T., Juliano, N., Ladd, C., and Lee, H. C. (2003) An overview of DNA methods for the identification and individualization of marijuana. Croat. Med. J. 44, 315–321.
ElSohly, M. (2003) Practical challenges to positive drug tests for marijuana. Clin. Chem. 49, 1037–1038.
Leson, G., Pless, P., Grotenhermen, F., Kalant, H., and ElSohly, M. A. (2001) Evaluating the impact of hemp food consumption on workplace drug tests. J. Anal. Toxicol. 25, 691–698.
Ross, S. A., Mehmedic, Z., Murphy, T. P., and Elsohly, M. A. (2000) GC-MS analysis of the total delta9-THC content of both drug-and fiber-type Cannabis seeds. J. Anal. Toxicol. 24, 715–717.
Bosy, T. Z. and Cole, K. A. (2000) Consumption and quantitation of delta-9-tetrahydrocan-nabinol in commercially available hemp seed oil products. J. Anal. Toxicol. 24, 562–6.
Mediavilla, V., Derungs, R., Känzig, A., and Mägert, A. (1997) Qualität von Hanfsamenöl aus der Schweiz. Agrarforschung 4, 449–451.
Lehmann, T., Sager, F., and Brenneisen, R. (1997) Excretion of cannabinoids in urine after ingestion of Cannabis seed oil. J. Anal. Toxicol. 21, 373–375.
Mediavilla, V. and Steinemann, S. (1997) Essential oil of Cannabis sativa L. strains. J. Int. Hemp Assoc. 4, 80–82.
Meier, C. and Mediavilla, V. (1998) Factors influencing the yield and the quality of hemp (Cannabis sativa L.) essential oil. J. Int. Hemp Assoc. 5, 16–20.
Lehmann, T. (1995) Chemical profiling of Cannabis sativa L., PhD thesis, University of Bern, Dep. of Pharmaceutical Sciences, Bern, Switzerland.
Ross, S.A. and ElSohly, M. A. (1996) The volatile oil composition of fresh and air-dried buds of Cannabis sativa. J. Nat. Prod. 59, 49–51.
Novak, J., Zitterl-Eglseer, K., Deans, S. G., and Franz, C. M. (2001) Essential oils of different cultivars of Cannabis sativa L. and their antimicrobial activity. Flavour Fragr. J. 16, 259–262.
McPartland, J. M. and Russo, E. B. (2001) Cannabis and Cannabis extracts: greater than the sum of their parts? J. Cann. Therap. 1, 103–132.
Hendriks, H., Malingré, T. M., Batterman, S., and Bos, R. (1977) Alkanes of the essential oil of Cannabis sativa. Phytochemistry 16, 719–721.
McPartland, J. and Mediavilla, V. (2002) Noncannabinoid components, in Cannabis and Cannabinoids-Pharmacology, Toxicology, and Therapeutic Potential (Grotenhermen, F., and Russo, E., eds.), Haworth Press, New York, pp. 401–409.
Vanhoenacker, G., Van Rompaey, P., De Keukeleire, D., and Sandra, P. (2002) Chemo-taxonomic features associated with flavonoids of cannabinoid-free Cannabis (Cannabis sativa subsp. sativa L.) in relation to hops (Humulus lupulus L.). Nat. Prod. Lett. 16, 57–63.
Barrett, M. L., Scutt, A. M., and Evans, F. J. (1986) Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia 42, 452–453.
Barrett, M. L., Gordon, D., and Evans, F. J. (1985) Isolation from Cannabis sativa L. of cannflavin-a novel inhibitor of prostaglandin production. Biochem. Pharmacol. 34, 2019–2024.
Leson, G., Pless, P., and Roulac, J. (1999) Hemp Foods and Oils for Health, Hemptech, Sebastopol, CA.
Ross, S., ElSohly, H., ElKashoury, E., and ElSohly, M. (1996) Fatty acids of Cannabis seeds. Phytochem. Anal. 7, 279–283.
Grotenhermen, F. (2002) Effects of Cannabis and the cannabinoids, in Cannabis and Cannabinoids-Pharmacology, Toxicology, and Therapeutic Potential (Grotenhermen, F. and Russo, E., eds.), Haworth Press, New York, pp. 55–65.
Grotenhermen, F. and Russo, E. (eds.) (2002) Cannabis and Cannabinoids-Pharmacology, Toxicology, and Therapeutic Potential, Haworth Press, New York, p. 439.
Iversen, L. (2003) Cannabis and the brain. Brain 126, 1252–1270.
Croxford, J. L. (2003) Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 17, 179–202.
Kumar, R., Chambers, W., and Pertwee, R. G. (2001) Pharmacological actions and therapeutic uses of Cannabis and cannabinoids. Anaesthesia 56, 1059–68.
Hirst, R. A., Lambert, D. G., and Notcutt, W. G. (1998) Pharmacology and potential therapeutic uses of Cannabis. Br. J. Anaesth. 81, 77–84.
Ashton, C. H. (1999) Adverse effects of Cannabis and cannabinoids. Br. J. Anaesth. 83, 637–49.
Williamson, E. M. and Evans, F. J. (2000) Cannabinoids in clinical practice. Drugs 60, 1303–1314.
Campbell, F. A., Tramèr, M. R., Carroll, D., Reynolds, D. J., Moore, R. A., and McQuay, H. J. (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. Br. Med. J. 323, 13–16.
.Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J., Moore, R. A., and McQuay, H. J. (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. Br. Med. J. 323, 16–21.
Walker, J. M. and Huang, S. M. (2002) Cannabinoid analgesia. Pharmacol. Ther. 95, 127–135.
Voth, E. A. and Schwartz, R. H. (1997) Medicinal applications of delta-9-tetrahydrocan-nabinol and marijuana. Ann. Int. Med. 126, 791–798.
McPartland, J. M. and Pruitt, P. L. (1999) Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana. Altern. Ther. 5, 57–62.
Wachtel, S. R., ElSohly, M. A., Ross, S. A., Ambre, J., and de Wit, H. (2002) Comparison of the subjective effects of delta-9-tetrahydrocannabinol and marijuana in humans. Psychopharmacology 161, 331–339.
Hart, C. L., Ward, A. S., Haney, M., Comer, S. D., Foltin, R. W., and Fischman, M. W. (2002) Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Psychopharmacology 164, 407–415.
Mechoulam, R., Parker, L. A., and Gallily, R. (2002) Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol. 42, 11S–19S.
Consroe, P. (1998) Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiol. Dis. 5, 534–551.
Bornheim, L. M., Kim, K. Y., Li, J., Perotti, B. Y., and Benet, L. Z. (1995) Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab. Dispos. 23, 825–831.
Meschler, J. P. and Howlett, A. C. (1999) Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses. Pharmacol. Biochem. Behav. 62, 473–480.
Russo, E. (2001) Hemp for headache: an in-depth historical and scientific review of can-nabis in migraine treatment. J. Cann. Ther. 1, 21–92.
Salgueiro, J. B., Ardenghi, P., Dias, M., Ferreira, M. B., Izquierdo, I., and Medina, J. H. (1997) Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol. Biochem. Behav. 58, 887–891.
Mitosinka, G. T., Thornton, J. I., and Hayes, T. L. (1972) The examination of cystolithic hairs of Cannabis and other plants by means of the scanning electron microscope. J. Forens. Sci Soc. 12, 521–529.
Thornton, J. I. and Nakamura, G. R. (1972) The identification of marijuana. J. Forens. Sci. Soc. 12, 461–519.
Gigliano, G. (2001) Cannabis sativa L.—botanical problems and molecular approaches in forensic investigations. Forens. Sci. Rev. 13, 2–17.
.Stearn, W. T. (1970) The Cannabis plant: botanical characteristics, in The Botany & Chemistry of Cannabis (Joyce, C. and Curry, S., eds.), J. & A. Churchill, London, p. 1.
Nordal, A. (1970) Microscopic detection of Cannabis in the pure state and in semi-combusted residues, in The Botany & Chemistry of Cannabis (Joyce, C. and Curry, S., eds.), J. & A. Churchill, London, pp. 61–68.
Petri, G., Oroszlan, P., and Fridvalszky, L. (1988) Histochemical detection of hemp tri-chomes and their correlation with the THC content. Acta Biol. Hung. 39, 59–73.
Bruni, A., Barni Comparini, I., and Menziani Andreoli, E. (1983) A histofluorescent procedure for identifying marijuana cannabinoids. Experientia 39, 886–888.
United Nations (1987) Recommended Methods for Testing Cannabis, ST/NAR/8, Division of Narcotic Drugs, United Nations, New York.
Bailey, K. (1979) The value of the Duquenois test for Cannabis-a survey. J. Forens. Sci. 24, 817–841.
Butler, W. (1962) Duquenois-Levine test for marijuana. J. Assoc. Off. Anal. Chem. 45, 597–600.
Tewari, S. N. and Sharma, J. D. (1982) Spot tests for Cannabis materials. Bull. Narc. 34, 109–112.
Pitt, C. G., Hendron, R. W., and Hsia, R. S. (1972) The specificity of the Duquenois color test for marihuana and hashish. J. Forens. Sci. 17, 693–700.
Mali, B. D. and Parulekar, P. P. (1988) Diazotized dapsone as a reagent for the detection of cannabinoids on thin-layer chromatographic plates. J. Chromatogr. 457, 383–386.
Baker, P. B., Gough, T. A., and Taylor, B. J. (1980) Illicitly imported Cannabis products: some physical and chemical features indicative of their origin. Bull. Narc. 32, 31–40.
Debruyne, D., Albessard, F., Bigot, M. C., and Moulin, M. (1994) Comparison of three advanced chromatographic techniques for Cannabis identification. Bull. Narc. 46, 109–121.
Pothier, J., Galand, N., and Viel, C. (1992) Rapid characterization of stupefacient and toxic substances by pressurized thin-layer chromatography. J. Toxicol. Clin. Exp. 12, 495–501.
Oroszlan, P., Verzar-Petri, G., Mincsovics, E., and Szekely, T. (1987) Separation, quantitation and isolation of cannabinoids from Cannabis sativa L. by overpressured layer chromatography. J. Chromatogr. 388, 217–224.
Ferioli, V., Rustichelli, C., Pavesi, G., and Gamberini, G. (2000) Analytical characterisation of hashish samples. Chromatographia 52, 39–44.
Debruyne, D., Moulin, M., Bigot, M. C., and Camsonne, R. (1981) Identification and differentiation of resinous Cannabis and textile Cannabis: combined use of HPLC and high-resolution GLC. Bull. Narc. 33, 49–58.
Tsatsakis, A. M., Tutudaki, M., Stiakakis, I., Dimopoulou, M., Tzatzarakis, M., and Michalodimitrakis, M. (2000) Characterisation of Cannabis plants phenotypes from illegal cultivations in Crete. Boll. Chim. Farm. 139, 140–145.
Ross, S. A. and ElSohly, M. A. (1996) The volatile oil composition of fresh and air-dried buds of Cannabis sativa. J. Nat. Prod. 59, 49–51.
Barni Comparini, I. and Centini, F. (1983) Packed column chromatography, high-resolution gas-chromatography and high pressure liquid chromatography in comparison for the analysis of Cannabis constituents. Forens. Sci. Int. 21, 129–137.
Harvey, D. J. (1990) Stability of cannabinoids in dried samples of Cannabis dating from around 1896-1905. J. Ethnopharmacol. 28, 117–128.
Turner, C. E., Bouwsma, O. J., Billets, S., and Elsohly, M. A. (1980) Constituents of Cannabis sativa L. XVIII-Electron voltage selected ion monitoring study of cannabinoids. Biomed. Mass Spectrom. 7, 247–256.
Brenneisen, R. and ElSohly, M. A. (1988) Chromatographic and spectroscopic profiles of Cannabis of different origins: PartI. J. Forens. Sci. 33, 1385–1404.
Bosy, T. Z. and Cole, K. A. (2000) Consumption and quantitation of delta-9-tetrahydrocan-nabinol in commercially available hemp seed oil products. J. Anal. Toxicol. 24, 562–566.
Lercker, G., Bocci, F., Frega, N., and Bortolomeazzi, R. (1992) Cannabinoid acids analysis. Farmaco 47, 367–378.
Vree, T. B. (1977) Mass spectrometry of cannabinoids. J. Pharm. Sci. 66, 1444–1450.
Novotny, M., Lee, M. L., Low, C. E., and Raymond, A. (1976) Analysis of marijuana samples from different origins by high-resolution gas-liquid chromatography for forensic application. Anal. Chem. 48, 24–29.
Raharjo, T. J. and Verpoorte, R. (2004) Methods for the analysis of cannabinoids in biological materials: a review. Phytochem. Anal. 15, 79–94.
Lehmann, T. and Brenneisen, R. (1995) High performance liquid chromatographic profiling of Cannabis products. J. Liq. Chromatogr. 18, 689–700.
Barni Comparini, I. and Centini, F. (1983) Packed column chromatography, high-resolution gas-chromatography and high pressure liquid chromatography in comparison for the analysis of Cannabis constituents. Forens. Sci. Int. 21, 129–37.
Zoller, O., Rhyn, P., and Zimmerli, B. (2000) High-performance liquid chromatographic determination of delta9-tetrahydrocannabinol and the corresponding acid in hemp containing foods with special regard to the fluorescence properties of delta9-tetrahydrocan-nabinol. J. Chromatogr. A 872, 101–110.
Baker, P. B., Gough, T. A., and Wagstaffe, P. J. (1983) Determination of the distribution of cannabinoids in Cannabis resin from Morocco using high-performance liquid chroma-tography. Part II. J. Anal. Toxicol. 7, 7–10.
Baker, P. B., Taylor, B. J., and Gough, T. A. (1981) The tetrahydrocannabinol and tetrahydrocannabinolic acid content of Cannabis products. J. Pharm. Pharmacol. 33, 369–372.
McDonald, P. A. and Gough, T. A. (1984) Determination of the distribution of cannabinoids in Cannabis resin from the Lebanon using HPLC. Part III. J. Chromatogr. Sci. 22, 282–284.
Brenneisen, R. (1984) Psychotropic drugs. II. Determination of cannabinoids in Cannabis sativa L. and in Cannabis products with high pressure liquid chromatography (HPLC). Pharm. Acta Helv. 59, 247–259.
Rustichelli, C., Ferioli, V., Baraldi, M., Zanoli, P., and Gamberini, G. (1998) Analysis of cannabinoids in fiber hemp plant varieties (Cannabis sativa) by high-performance liquid chromatography. Chromatographia 8, 215–222.
Baker, P. B., Fowler, R., Bagon, K. R., and Gough, T. A. (1980) Determination of the distribution of cannabinoids in Cannabis resin using high performance liquid chromatography. J. Anal. Toxicol. 4, 145–152.
Nakahara, Y. and Tanaka, K. (1988) Studies on discrimination of confiscated Cannabis products by high performance liquid chromatography with electrochemical detector. Eisei Shikenjo Hokoku, Bulletin of National Institute of Hygenic Sciences, pp.11–18.
Rustichelli, C., Ferioli, V., Vezzalini, F., Rossi, M. C., and Gamberini, G. (1996) Simultaneous separation and identification of hashish constituents by coupled liquid chroma-tography-mass spectrometry (HPLC-MS). Chromatographia 43, 129–134.
Lurie, I. S., Meyers, R. P., and Conver, T. S. (1998) Capillary electrochromatography of cannabinoids. Anal. Chem. 70, 3255–3260.
Backstrom, B., Cole, M. D., Carrott, M. J., Jones, D. C., Davidson, G., and Coleman, K. (1997) A preliminary study of the analysis of Cannabis by supercritical fluid chromatography with atmospheric pressure chemical ionisation mass spectroscopic detection. Sci. Justice 37, 91–97.
Miller Coyle, H., Ladd, C., Palmbach, T., and Lee, H. C. (2001) The green revolution: botanical contributions to forensics and drug enforcement. Croat. Med. J. 42, 340–345.
Miller Coyle, H., Palmbach, T., Juliano, N., Ladd, C., and Lee, H. C. (2003) An overview of DNA methods for the identification and individualization of marijuana. Croat. Med. J. 44, 315–321.
Cole, M. D. and Linacre, A. M. T. (2002) The identification of controlled plant drugs using phytochemistry and DNA. Curr. Topics Phytochem. 5, 129–140.
Linacre, A. and Thorpe, J. (1998) Detection and identification of Cannabis by DNA. Forens. Sci. Int. 91, 71–76.
Siniscalco Gigliano, G., Caputo, P., and Cozzolino, S. (1997) Ribosomal DNA analysis as a tool for the identification of Cannabis sativa L. specimens of forensic interest. Sci. Justice 37, 171–174.
Gillan, R., Cole, M., Linacre, A., Thorpe, J. W., and Watson, N. D. (1995) Comparison of Cannabis sativa by random amplification of polymorphic DNA (RAPD) and HPLC of cannabinoids: a preliminary study. Sci. Justice 35, 169–177.
Miller Coyle, H., Sutler, G., Abrams, S., et al. (2003) A simple DNA extraction method for Marijuana samples used in amplified fragment length polymorphism (AFLP) analysis. J. Forens. Sci. 48, 343–347.
Hsieh, H. M., Hou, R. J., Tsai, L. C., et al. (2003) A highly polymorphic STR locus in Cannabis sativa. Forens. Sci. Int. 131, 53–58.
Gilmore, S., Peakall, R., and Robertson, J. (2003) Short tandem repeat (STR) DNA markers are hypervariable and informative in Cannabis sativa: implications for forensic investigations. Forens. Sci. Int. 131, 65–74.
Kojoma, M., Iida, O., Makino, Y., Sekita, S., and Satake, M. (2002) DNA fingerprinting of Cannabis sativa using inter-simple sequence repeat (ISSR) amplification. Planta Med. 68, 60–63.
Gigliano, G. (1998) Identification of Cannabis sativa L. (Cannabaceae) using restriction profiles of the Internal Transcribed Spacer II (ITS2). Sci. Justice 38, 225–230.
Alghanim, H. J. and Almirall, J. R. (2003) Development of micro satellite markers in Cannabis sativa for DNA typing and genetic relatedness analyses. Anal. Bioanal. Chem. 376, 1225–1233.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, New Jersey
About this chapter
Cite this chapter
Brenneisen, R. (2007). Chemistry and Analysis of Phytocannabinoids and Other Cannabis Constituents . In: ElSohly, M.A. (eds) Marijuana and the Cannabinoids. Forensic Science And Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-947-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-947-9_2
Publisher Name: Humana Press
Print ISBN: 978-1-58829-456-2
Online ISBN: 978-1-59259-947-9
eBook Packages: MedicineMedicine (R0)